Based on SEC filing data. An early-stage biotech company based in Seattle, Washington that was founded in 2013. The company raised $33,750 in equity funding and is structured as a limited liability company.
Get notified the moment Kineta Viral Hemorrhagic Fever, LLC files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.